Innovex International, Inc.·4

Feb 27, 8:14 PM ET

Amberjack Management, LLC 4

4 · Innovex International, Inc. · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Innovex (INVX) 10% Owner Amberjack Capital Sells 6.61M Shares

What Happened

  • Amberjack Capital Partners, L.P. (reported as a 10% owner) sold a total of 6,612,500 shares of Innovex International, Inc. on February 27, 2026. The sales were reported as dispositions (code S) in connection with an underwritten secondary offering. The filing lists a per-share receipt of $24.59125 (public offering price was $25.75), for aggregate proceeds of about $162.6 million.

Key Details

  • Transaction date: 2026-02-27; reported price received per share: ~$24.59125 (public offering price was $25.75 before underwriting discounts).
  • Shares sold (by line items reported): 4,902,244; 1,144,635; 271,279; 234,009; 116; 60,217 — total 6,612,500 shares.
  • Aggregate proceeds: approximately $162.6 million (sum of the reported dispositions).
  • Shares owned after transaction: not specified in the excerpt provided; see the full Form 4/filing for post-transaction holdings.
  • Notable footnotes: sales consisted of shares held directly by Amberjack-affiliated funds and were sold in the Offering; Amberjack Funds received the offering proceeds net of underwriting discounts. Filing explains the fund/general-partner structure and notes that certain individuals (e.g., Jason Turowsky) may be deemed to have control but disclaim beneficial ownership beyond pecuniary interests.
  • Filing notes: this Form 4 is the second of two filings relating to the same event because there are more than 10 reporting persons in total. No late-filing indication appears in the provided text.

Context

  • This was a coordinated institutional sale in an underwritten secondary offering — not an individual insider selling on the open market — so it reflects placement of fund-held shares rather than an executive personal liquidity event. For retail investors, purchases generally carry more signal than routine institutional secondary sales; these types of offerings commonly involve underwriting discounts and pre-arranged distributions of fund holdings.
  • Transaction code: S = Sale/Disposition.

Insider Transaction Report

Form 4
Period: 2026-02-27
Transactions
  • Sale

    Common Stock

    [F1][F7][F8][F9][F10]
    2026-02-27$24.59/sh4,902,244$120,552,55316,871,374 total(indirect: By Amberjack Capital Fund II, L.P.)
  • Sale

    Common Stock

    [F2][F7][F8][F9][F10]
    2026-02-27$24.59/sh1,144,635$28,148,0633,939,330 total(indirect: By Innovex Co-Invest Fund II, L.P.)
  • Sale

    Common Stock

    [F3][F7][F8][F9][F10]
    2026-02-27$24.59/sh271,279$6,671,103933,624 total(indirect: By Innovex Co-Invest Fund, L.P.)
  • Sale

    Common Stock

    [F4][F7][F8][F9][F10]
    2026-02-27$24.59/sh234,009$5,754,586805,355 total(indirect: By Intervale Capital Fund II, L.P.)
  • Sale

    Common Stock

    [F5][F7][F8][F9][F10]
    2026-02-27$24.59/sh116$2,853399 total(indirect: By Intervale Capital Fund II-A, L.P.)
  • Sale

    Common Stock

    [F6][F7][F8][F9][F10]
    2026-02-27$24.59/sh60,217$1,480,814207,240 total(indirect: By Intervale Capital Fund III, L.P.)
Footnotes (10)
  • [F1]Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F10](Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
  • [F2]Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F3]Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F4]Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F5]Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F6]Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
  • [F7]The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
  • [F8](Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
  • [F9]By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.

Documents

1 file
  • 4
    form4.xmlPrimary